2,3,5,6-Tetramethoxyphenethylamine

TeMPEA-3
Clinical data
Other names2,3,5,6-TeMPEA; TeMPEA-3
ATC code
  • None
Identifiers
  • 2-(2,3,5,6-tetramethoxyphenyl)ethanamine
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H19NO4
Molar mass241.287 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C(=C1OC)CCN)OC)OC
  • InChI=1S/C12H19NO4/c1-14-9-7-10(15-2)12(17-4)8(5-6-13)11(9)16-3/h7H,5-6,13H2,1-4H3
  • Key:MRCWRNATBFUERI-UHFFFAOYSA-N

2,3,5,6-Tetramethoxyphenethylamine (2,3,5,6-TeMPEA), also known as TeMPEA-3, is a drug of the phenethylamine family related to the psychedelic drug mescaline (3,4,5-trimethoxyphenethylamine). It is one of the possible positional isomers of tetramethoxyphenethylamine (TeMPEA).

The in-vitro metabolism and effects of TeMPEA-3 on behavior in animals have been studied. Unlike mescaline, TeMPEA-3 was inactive in the conditioned avoidance response test in rats. The effects of TeMPEA-3 in humans have not been reported and are unknown.

The drug was first described in the scientific literature by 1955. TeMPEA-3 was included as an entry in Alexander Shulgin's 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. It is a controlled substance in Canada under phenethylamine blanket-ban language.

See also